Protein expression has been compared in human substantia nigra specimens from Parkinson's disease (PD) patients and from controls, and 44 proteins expressed in this midbrain region were identified by peptide mass fingerprinting. Among them, nine showed changes in their abundance. L and M neurofilament chains are less abundant in PD specimens, whereas peroxiredoxin II, mitochondrial complex III, ATP synthase D chain, complexin I, profilin, L-type calcium channel d-subunit, and fatty-acid binding protein are significantly more present in PD samples than in controls. Besides the consolidated view of oxidative stress involvement in PD pathogenesis, suggested by overexpression of mitochondrial and reactive oxygen species (ROS)-scavenging proteins, these results indicate a possible potentiation mechanism of afferent signals to substantia nigra following degeneration of dopaminergic neurons.
Introduction
Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease (AD), with a prevalence of about 2% among people over the age of 65 years [1, 2] . The characteristic motor symptoms are associated with the depletion of dopaminergic melanin-containing neurons in the substantia nigra pars compacta (SNpc) and a consequent loss of dopamine in the striatum [1] . Another important pathological feature is the presence, especially in SNpc neurons, of eosinophilic cytoplasmic inclusion bodies (Lewy bodies, LB) [1, 3, 4] . LB show a strong staining with anti-a-synuclein antibodies [5] , a presynaptic protein involved in a familial form of the disease [6, 7] , present as the main filamentous component [8] [9] [10] . In vitro studies showed that both mutated and wild-type a-synucleins do form fibrils similar to those of LB; moreover, a-synuclein molecules carrying either one of the two point mutations observed in the familial PD will aggregate faster than the wild-type protein [11] [12] [13] . Recently, the effects of changes in the a-synuclein sequence on the enhanced susceptibility of cells to reactive oxygen species (ROS) have been reported [14] [15] [16] [17] , providing a pathogenic link between a-synuclein anomalies and a putative role of ROS in the cell death mechanisms in PD [18] [19] [20] [21] .
Substantia nigra (SN) is a preferential candidate to oxidative damage, since it contains oxidizable dopamine, neuromelanin, polyunsaturated fatty acids, iron, and relatively low antioxidant complement [21] . In this context, mitochondria are involved in a number of cellular reactions that potentially lead to the formation of ROS, like superoxide anions, hydroxyl radicals, and hydrogen peroxide. Complexes I and III in particular are associated with superoxide production, and the inhibition of these complexes results in increased free radical production. Mito-chondria contain antioxidant defence systems, such as glutathione, catalase, and superoxide dismutase, to carefully balance free radical production and detoxification. Oxidative stress is believed to be important in the ageing process and details of how ROS are produced from various intra-and extracellular sources as well as the cellular defence mechanisms and responses to oxidative stress have recently been extensively reviewed [22, 23] .
Nowadays, the occurrence of a tight association of proteins to form insoluble supramolecular aggregates is considered to be the basis of a number of neurological diseases, both familial and sporadic. Self-aggregation of a-synuclein, wrong folding of the prion protein, defective cleavage of the amyloid b-peptide and hyperphosphorylation of the tau protein all lead to changes in the dynamics of cytosolic proteins and eventually the formation of macroscopic aggregates in PD, spongiform encephalopathy, and AD, respectively [8, 24] . An analysis of the water dynamics in ex vivo specimens of SNpc has shown a differential deposition of cytosolic proteins with respect to age-matched controls [25] . It has recently been proposed that misfolded a-synuclein could form channels in dopamine storage vesicles, thus contributing to the formation of cytoplasmic ROS due to dopamine oxidative catabolism [26] .
In the present work, we describe a proteomic analysis of SN tissue in order to evaluate changes in the expression level of proteins that could provide information on the pathogenetic mechanism and on the pathways herein involved. To this purpose, we performed a two-dimensional electrophoretic (2-DE) separation of proteins extracted from ex vivo specimens from controls and PD patients. Forty-four proteins have been identified by peptide mass fingerprinting and their expression levels have been compared and statistically evaluated. Among them, nine proteins showed differential expression in PD patients respect to age-matched controls.
Materials and methods

Chemicals
Immobilized pH gradient (IPG) strips, IPG buffer, acrylamide, and Coomassie Brilliant Blue R-250 were purchased from Amersham Biosciences (Uppsala, Sweden). Modified trypsin was from Promega (Madison, WI, USA). ZipTip C18 were from Millipore (Bedford, MA, USA). The protease inhibitor mix (from Sigma Chemical, St. Louis, MO, USA) contained 4-(2-aminoethyl)benzenesulfonyl fluoride (AEBSF), pepstatin A, trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane (E-64), bestatin, leupeptin, and aprotinin, and was used according to manufacturer's instructions. All other chemicals were obtained from Sigma Chemical and used without further purification.
Tissues
Specimens of human SN from four patients having known PD history (sex 3 M, 1 F, aged 75 6 3 years; deceased 13 6 2 years after diagnosis; postmortem delay 4 h 38 min 6 26 min; brain weight 1156 6 94 g) were provided by the Nederlandse Hersenbank (the Netherland's Brain Bank), Amsterdam. Each specimen was accompanied by histopathological report, showing depletion of pigmented dopaminergic neurons and the occurrence of extracellular neuromelanin granules as well as LB in surviving neurons. Four control specimens (sex 3 M, 1 F, aged 70 6 8 years; postmortem delay 6 h 19 min 6 1 h 11 min; brain weight 1441 6 127 g), not affected by neurodegenerative disorders, have been obtained from the same brain bank, also with histopathological report. SN have been excised from thawed autoptic specimens in order to refine the region of interest by cutting the surrounding unpigmented area using ceramic tools to avoid metal contamination of the samples. For less-pigmented PD tissues, a corresponding area has been removed. When present, blood clots have been removed before sample processing.
Protein extraction
Specimens (0.5-0.7 g) were homogenized (20 up-anddown strokes with a Teflon homogenizer followed by five passages through a 22-gauge needle) in 3 mL lysis solution (7 M urea, 2 M thiourea, 4% v/v CHAPS, 0.05 mL protease inhibitor mix) per mg tissue. After centrifugation at 21 0006g for 30 min at 207C supernatants were recovered; protein content was estimated with the 2D-Quant kit (Amersham Biosciences).
2-DE and data analysis
2-DE was performed according to Jacobs [27] , with some modifications. Samples (, 1 mg for Coomassie staining, , 100 mg for silver staining) were diluted to 250 mL with a buffer containing 7 M urea, 2 M thiourea, 4% CHAPS, 0.5% IPG buffer 3-10, 2 mM tributylphosphine, and traces of bromophenol blue and loaded onto 13 cm IPG DryStrips with a nonlinear pH 3-10 gradient by in-gel rehydration (1 h at 0 V, 10 h at 30 V). IEF was performed at 167C on an IPGphor (Amersham Biosciences) according to the following schedule: 1 h at 200 V, 30 min of a linear gradient to 3500 V, 3 h at 3500 V, 2.5 h of a linear gradient to 8000 V, 6 h at 8000 V. Prior to SDS-PAGE, the IPG strips were equilibrated for 2630 min in 50 mM Tris-HCl, pH 8.8, 6 M urea, 30% glycerol, 2% SDS, and traces of bromophenol blue containing 1% DTT for the first equilibration step and 2.5% iodoacetamide for the second one. SDS-PAGE was performed using 12.5% T, 2.6% C 1.5 mm thick separating polyacrylamide gels without stacking gel, using a Hoefer SE 600 system (Amersham Biosciences). The second dimension was carried out at 45 mA/gel at 167C and was terminated when the bromophenol dye front had migrated to the lower end of the gels. Carbamylated pI calibration markers (Amersham Biosciences) and molecular mass marker proteins (14-66 kDa from Sigma Chemical) were used for calibration of the molecular mass. The gels were stained either with Coomassie Brilliant Blue R-250 or according to Sinha's silver staining method [28] . After staining, gels were scanned with the ImageMaster Labscan V3.0 (Amersham Biosciences) and images were analyzed with ImageMaster 2D Elite V4.01 software package (Amersham Biosciences). Coomassie-stained spots were quantified on the basis of their relative volume (the spot volume divided by the total volume over the whole set of gel spots) and statistically analyzed according to the nonparametric Wilcoxon test. Relationships were considered statistically significant when p , 0.05.
Tryptic digestion of 2-DE gel spots
Coomassie-stained spots were manually excised and destained overnight with 40% ethanol in 25 mM ammonium bicarbonate. Gel pieces were washed twice with 25 mM ammonium bicarbonate and desiccated three times with acetonitrile. Each piece was then reswollen in 25 mM ammonium bicarbonate containing 1.2 mg of modified porcine trypsin and digestion proceeded overnight at 377C. Peptides were extracted by sonication in 25 mM ammonium bicarbonate and loaded on ZipTip C18 .
MALDI-TOF-MS
Each peptide sample was eluted from ZipTip C18 with a saturated solution of a-cyano-4-hydroxycinnamic acid in 70% acetonitrile and 0.2% TFA and 0.5 mL was spotted directly on a MALDI target plate. MALDI mass spectra were acquired in the positive reflectron ion mode with delayed extraction on a Reflex III time of flight instrument (Bruker Daltonics, Bremen, Germany) equipped with a 337 nm nitrogen laser. Ion acceleration voltage was set to 20.00 kV, the reflector voltage was set to 23.00 kV and the first extraction plate was set to 17.05 kV. Mass spectra were obtained by averaging 600 laser shots. Calibration of the spectra was performed internally by a two-points linear fit, using the autolysis products of trypsin at m/z 842.50 and 2211.10.
Database search
Database search with the peptide masses was performed against the Swiss-Prot database using the PeptIdent search algorithm (http://www.expasy.ch/tools/peptident.html). Mass tolerance for the monoisotopic peptide masses was set to 50 ppm.
Results
Proteins were extracted from four control specimens and four PD specimens, and analyzed in parallel by 2-DE, using both Coomassie Brilliant Blue and silver staining. With silver staining 50-100% more spots could be visualized (Fig. 1) . By considering all the data sets, no significant differences were found between controls and PD patients in terms of appearance, disappearance or shift of any spot, with both staining methods.
In order to investigate how the overall expression of proteins is potentially affected in PD with respect to controls, 142 spots were selected for further analysis from the Coomassie-stained gels. Only spots that were mostly expressed or better focalized were chosen. In both specimens, the amount of protein present in each spot was densitometrically measured and statistically evaluated. Table 1 (see Addendum) reports isoelectric points and molecular weights, as deduced from the gel, and statistical analysis of spot volumes, according to Wilcoxon test, for each protein. Figure 2 shows the position of the 142 spots in a Coomassie-stained gel from a control specimen.
To build a map of the proteins extracted from human SN specimens, we tried to identify by peptide mass fingerprinting the spots that had been selected for statistical analysis. Spots were excised, both from control and PD gels, and digested with trypsin. Peptide masses were Table 1. used to query the database. In order to evaluate protein identifications, we considered not only the percentage of sequence coverage (at least 20%), as indicated in Table 1 , but also the number of matching peptides (at least five) and the gap between the accepted protein and the first excluded one in the list of candidates provided by the database search (at least a difference of three peptides). The procedure was successful, and 44 proteins were identified.
As it can be noticed from Table 1 
Discussion
Proteomics is a powerful methodology to investigate how protein expression is affected in the pathogenesis of a disease process. Nevertheless, there are to date a limited number of reports in the field of neurodegenerative disorders compared to other classes of diseases [29] . One of the limits of the technique is the limited number of protein spots that can be visualized on a single gel. Only the most expressed proteins are recognized, and very large or very small proteins cannot be adequately resolved. Also the range of pI values is a matter of concern; although nonlinear pH gradients are commonly used, proteins having extreme pI values cannot focalize properly. Moreover, hydrophobic membrane proteins are difficult to resolve. Nonetheless, information on major proteins may also be of use, mainly for those proteins involved in the energetic metabolism of the cell. In a preliminary report, we observed that (mitochondrial) Mn-SOD and dihydropteridine reductase were increased twofold in PD with respect to controls, although specimen variability did not allow to have statistically significant figures [30] .
Among the 44 proteins identified in this work, nine show significant changes in their level of expression. In particular, higher expression of peroxiredoxin II is in agreement with the oxidative stress hypothesis in PD [18, 23] . Peroxiredoxin II has been recently reported to be more expressed in the frontal cortex of PD, AD, and Down syndrome patients [31] . Peroxiredoxins are sacrificial antioxidants, i.e., instead of catalyzing ROS oxidation/ reduction they react themselves with ROS. In this process, available protein thiols (Cys-SH) are oxidized to sulfinyl residues (Cys-SO 2 2 ) with a consequent reduction of the pI. To the peroxiredoxin family belongs the DJ-1 protein as well; recently, a large deletion in the DJ-1 gene was reported to cosegregate with early-onset PD in a consanguineous Dutch family; moreover, a L166P mutation was found in an Italian family [32] . DJ-1 is known to interact with c-myc and to increase cell transformation, and to inhibit the RNA-binding ability of a cAMP-responsive multiprotein complex that includes glyceraldehyde-3-phosphate dehydrogenase [19] . It has also been supposed that DJ-1 acts as a ROS scavenger, thus modulating oxidant stress conditions. DJ-1 behaves as a hydroperoxide-responsive protein, that is converted into a variant with a more acidic pI in response to oxidative stress, suggesting a function as an antioxidant protein [33, 34] . These authors also described a similar behavior for peroxiredoxins in the case of human umbilical vein endothelial cells in response to oxidative stress [35] .
Actually, there are suggestions that ROS, by-products of the oxidative metabolic pathway, may damage cell membranes through addition to unsaturated bonds in the lipid bilayer [18] . Oxidant stress conditions may, in turn, be strictly connected to excitotoxicity or to mitochondrial dysfunction [23, 36] .
A reduced complex I activity was first identified in the SN of post mortem PD brain [23, 37] . Other brain areas showed normal oxidative phosphorylation activity [23, 37, 38] . Complex I defect is specific to PD and selective for the SN, but not related to the formation of LB [23] . Additional defects in complexes II and III were reported as well [39, 40] . Mitochondrial changes in PD could either be the result from inherited mutations in the mitochondrial respiration proteins or a consequence of environmental factors and/or sporadic somatic mutations that compromise normal mitochondrial activity [23] . We report that mitochondrial complex III (ubiquinol cytochrome c reductase) shows a two-to threefold increase on two independent spots, and mitochondrial complex V (ATP synthase) has a twofold higher abundance in PD specimens. Therefore, lower activity previously reported in the literature should be related to the inhibition of mitochondrial enzymes in PD rather than a reduction in their expression level; thus, the increased expression observed here could be related to a compensatory mechanism. In both approaches, however, it is not possible to distinguish the contribution of nigral neurons from that of glial cells in SNpc homogenates.
Complexin I, profilin, and L-type calcium channel d subunit all appear to be more expressed in PD patients. Complexins are particularly abundant in presynaptic terminals, where they play an important role in modulating neurotransmitter release by exocytosis [41] . It has been suggested that complexin overexpression could enhance the probability of vesicle fusion upon influx of Ca 21 ions by increasing the number of vesicles close to full fusions.
It appears of peculiar interest the fact that L-type channels are more expressed in PD, as it was reported for hippocampus specimens from AD patients [42] . Increased density of L-type Ca 21 channels was actually associated to selective neuronal death in hippocampus in AD. These channels allow Ca 21 influx after a change in membrane potential due to glutamate binding to AMPA/kainate receptors. Also in PD, the increase of calcium influx might constitute an additional risk factor for involved neurons.
Actually, most of the results described here concern presynaptic proteins; since our specimens are composed by mesencephalic SN, the findings described are probably related to modifications of afferent fibers to nigral dopaminergic neurons as a consequence of the extensive SN cell death. In this view, two possible considerations could be made: first, the increase of presynaptic proteins in afferent terminals could be a mechanism to increase dopamine release by nigrostriatal neurons; second, this possible afferent hyperactivity could also involve glutamatergic fibers from subthalamic nucleus, supporting, at least partially, the excitotoxic hypothesis for SN degeneration [43] . Concerning profilin, it is a cytoskeletoninteracting protein that binds to actin monomers resulting in cytoskeletal changes. This finding could therefore be suggestive of modifications of neurofilaments at the SNpc level that takes place during the neurodegenerative process of PD. Unlike a similar work on AD brain areas [44] , cytoplasmic Cu,Zn-SOD (spot 109) and a-crystallin B chain (spots 102 and 103) do not appear here to be pres-ent in increased amount in PD SN tissue with respect to the controls. Ubiquitin (spot 142) appears in all maps with comparable intensities. This aspect has to be related to the hypothesis that an impairment in UCH-L1 activity [45] , that would reduce the availability of ubiquitin monomers for further ubiquitin tagging of proteins to be degraded, is a minor factor in sporadic PD [46] .
In conclusion, we have identified proteomic coordinates of 44 proteins expressed in human SN and a comparison between controls and PD patients have been made. Our findings are consistent with the view of oxidative stress involvement in PD pathogenesis, as suggested by overexpression of mitochondrial and ROS-scavenging proteins. Moreover, our work provides information about a possible potentiation mechanism of afferent signals to SN following degeneration of dopaminergic neurons. Finally, this extensive application of the proteomic approach to understand the molecular basis of PD demonstrates the great potentiality of this methodology in the field of neurodegenerative disorders. 
